M. Micaelo

Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.

Jacques P. Brown, L. Hofbauer, J. Wark, 2014, Bone.

[Perceived pain and weather changes in rheumatic patients].

F. Barcelos, E. Simões, A. Faustino, 2007, Acta Reumatológica Portuguesa.

Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial

M. Boers, F. Buttgereit, R. Ionescu, 2019, Scandinavian journal of rheumatology.

Delayed diagnosis of occult phosphaturic mesenchymal tumor in the foot

Marino Machado, J. Correia, F. Jonge, 2021, Radiology Case Reports.

Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.

Jacques P. Brown, L. Hofbauer, J. Wark, 2014, Bone.